Related Experiment Video

Updated: Apr 28, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

13.8K

Targeted therapies for treatment of recurrent ovarian cancer

Rachel N Grisham1, David M Hyman1, Gopa Iyer1

  • 1Memorial Sloan-Kettering Cancer Center, New York, New York.

Clinical Advances in Hematology & Oncology : H&O
|June 14, 2014
PubMed

Insights

Ovarian cancer is a leading cause of death. This review explores targeted therapies for recurrent ovarian cancer, offering new hope for patients with advanced disease.

Area of Science:

  • Gynecologic Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Epithelial ovarian cancer (EOC) is the leading cause of death from gynecologic malignancies in the US.
  • Most patients present with advanced-stage disease, and despite initial treatment, relapse is common.
  • Understanding molecular differences in EOC subtypes drives new targeted treatment strategies.

Purpose of the Study:

  • To review promising targeted therapeutics for recurrent ovarian cancer.
  • To highlight advances in treating advanced and relapsed EOC.
  • To provide an overview of current targeted therapy options.

Main Methods:

  • Literature review of targeted therapeutics for recurrent ovarian cancer.
  • Analysis of recent advances in molecularly targeted drug development.
  • Synthesis of data on efficacy and application of novel therapies.

Main Results:

  • Targeted therapies show promise in overcoming resistance to conventional chemotherapy.
  • Several molecularly targeted agents are being investigated for recurrent EOC.
  • Advances in understanding EOC subtypes inform personalized treatment approaches.

Conclusions:

  • Targeted therapies represent a significant advancement in managing recurrent ovarian cancer.
  • Personalized medicine based on molecular profiling is crucial for improving outcomes.
  • Continued research into novel targeted agents is essential for combating EOC mortality.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K
Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines11:50

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

Published on: September 10, 2014

13.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K